TGA Approval

SEEBRI BREEZHALER glycopyrronium (as bromide) 50 microgram powder for inhalation (in capsule) blister (191517)

ARTG ID

191517

ARTG Name

SEEBRI BREEZHALER glycopyrronium (as bromide) 50 microgram powder for inhalation (in capsule) blister

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

November 12, 2012

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/a9f3fbd18c899afa28804c55d255dc40.pdf

https://medical-cdn.nocode.com/drug_tga/889a2929807bbc8ee64d7c50ae81a2ad.pdf

Ingredient Name

glycopyrronium bromide

Empowering clinical research with data-driven insights and AI-powered tools.

SEEBRI BREEZHALER glycopyrronium (as bromide) 50 microgram powder for inhalation (in capsule) blister (191517) - TGA 批准文号 | MedPath